Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sheila Soh"'
Autor:
Sheila, Soh, S Tiong, Ong
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 54(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08f91976791ba483c44deb1570df8df2
https://pubmed.ncbi.nlm.nih.gov/24064821
https://pubmed.ncbi.nlm.nih.gov/24064821
Autor:
Naoto Takahashi, V. S. Nadarajan, Yijun Ruan, Anbupalam Thalamuthu, Wing-Kin Sung, Xing Yi Woo, Hae Tha Mya, Sheila Soh, Xiaoan Ruan, Wen Chun Juan, Kazutoshi Isobe, Markus M. Nöthen, Wan-Teck Lim, John W.J. Huang, Hein Than, Yao Fei, L.Y. Yang, Chia-Tien Chang, Dianne Poh, Noan-Minh Chau, Axel M. Hillmer, Liang Piu Koh, Ai Leen Ang, Gee Fung How, Mei-Kim Ang, Yeow Tee Goh, Lay Cheng Lim, Tan Min Chin, Daniel Shao-Weng Tan, Wee Joo Chng, Balram Chowbay, Audrey S.M. Teo, Hiroyuki Mano, Ju Ee Seet, Niranjan Nagarajan, Quan Sing Ng, Shenli Zhang, Pramila N. Ariyaratne, Atif Shahab, Wan Ting Poh, Manabu Soda, Patrick Tan, Yasushi Yatabe, Kenichi Sawada, Vikrant Kumar, Ross A. Soo, Tien Yin Wong, Valere Cacheux-Rataboul, Charles Chuah, Eng Huat Tan, John Carson Allen, King Pan Ng, Wah Heng Lee, S. Tiong Ong, Tun Kiat Ko
Publikováno v:
Nature medicine. 18(4)
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and epidermal growth factor receptor-mutated non-small-cell lung cancer (EGFR NSCLC). However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f59fffa8f03bafce17db3a749469cb
https://pubmed.ncbi.nlm.nih.gov/25295933
https://pubmed.ncbi.nlm.nih.gov/25295933
Autor:
Naoto Takahashi, S. Tiong Ong, Win Kin Sung, Wee Joo Chng, Joanna H.J. Tan, Audrey S.M. Teo, Simeen Malik, Thushangi N. Pathiraja, Peiyong Guan, Patrick Tan, Pauline Ng, Xin Xuan Sheila Soh, Qiangze Hoi, Ravi Bhatia, Asif Javed, Wah Heng Lee, Axel M. Hillmer, Tun Kiat Ko, Chandana Tennakoon, King Pan Ng, Charles Chuah
Publikováno v:
Blood. 126:3737-3737
The transition from chronic phase (CP) to blast crisis (BC) chronic myeloid leukemia (CML) is characterized by reprogramming of the CML transcriptome (Radich et al. PNAS 2006), and shortened survival. Current models propose genomic instability as cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb84d58e0189ceae21260409a0e2ca9f
https://doi.org/10.1182/blood.v126.23.3737.3737
https://doi.org/10.1182/blood.v126.23.3737.3737
Autor:
Sabine Cerny-Reiterer, Peter Valent, Asif Javed, Wah Heng Lee, Steve Rozen, Win Kin Sung, Wee Joo Chng, Axel M. Hillmer, Thushangi N. Pathiraja, Naoto Takahashi, Peiyong Guan, Kris C. Wood, Xin Xuan Sheila Soh, S. Tiong Ong, Audrey S.M. Teo, Tun Kiat Ko, Charles Chuah, Patrick Tan, Ravi Bhatia, Chandana Tennakoon, Willie Yu, Peter S. Winter, Joanna H.J. Tan, King Pan Ng, Qiangze Hoi, Pauline Ng, Simeen Malik
Publikováno v:
Blood. 126:2764-2764
Current models of CML blast crisis (BC) propose that expression of BCR-ABL results in genomic instability and the acquisition of genetic alterations that affect cell proliferation and survival, self-renewal and differentiation. To characterize the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4f82279a99033345aba1be5b48309eb
https://doi.org/10.1182/blood.v126.23.2764.2764
https://doi.org/10.1182/blood.v126.23.2764.2764
Autor:
Yao Fei, Axel M. Hillmer, Yeow Tee Goh, Shenli Zhang, John Carson Allen, Pramila N. Ariyaratne, Kazutoshi Isobe, King Pan Ng, Markus M. Nöthen, Charles Chuah, Wah Heng Lee, Hiroyuki Mano, V. S. Nadarajan, Yijun Ruan, Eng Huat Tan, Vikrant Kumar, Niranjan Nagarajan, Noan-Minh Chau, Xiaoan Ruan, Atif Shahab, Manabu Soda, Yasushi Yatabe, S. Tiong Ong, Mei-Kim Ang, Wing-Kin Sung, Daniel Shao-Weng Tan, Wee Joo Chng, Dianne Poh, John W.J. Huang, Audrey S.M. Teo, Sheila Soh, Xing Yi Woo, Tien Yin Wong, Patrick Tan, Tan Min Chin, Kenichi Sawada, Tun-Kiat Ko, Lay Cheng Lim, Liang Piu Koh, Wan Ting Poh, Ross A. Soo, Ju Ee Seet, Wan-Teck Lim, Hein Than, Quan Sing Ng, Wen Chun Juan, L.Y. Yang, Naoto Takahashi, Anbupalam Thalamuthu, Valere Cacheux-Rataboul
Publikováno v:
Cancer Research. 72:1911-1911
The use of tyrosine kinase inhibitors (TKI) to target oncogenic kinases has led to remarkable responses in patients with chronic myeloid leukemia (CML) and EGFR-mutated non-small cell lung cancer (EGFR NSCLC). However, a significant subset of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fddafff38b2a27b18b42d272285f2c2
https://doi.org/10.1158/1538-7445.am2012-1911
https://doi.org/10.1158/1538-7445.am2012-1911